Related references
Note: Only part of the references are listed.A Novel Time-Activity Information-Sharing Approach Using Nonlinear Mixed Models for Patient-Specific Dosimetry with Reduced Imaging Time Points: Application in SPECT/CT After 177Lu-DOTATATE
Theresa P. Devasia et al.
JOURNAL OF NUCLEAR MEDICINE (2021)
Feasibility of Single-Time-Point Dosimetry for Radiopharmaceutical Therapies
Xinchi Hou et al.
JOURNAL OF NUCLEAR MEDICINE (2021)
Radiation Dosimetry in Lu-177-PSMA-617 Therapy Using a Single Posttreatment SPECT/CT Scan: A Novel Methodology to Generate Time- and Tissue-Specific Dose Factors
Price A. Jackson et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
Will SPECT/CT Cameras Soon Be Able to Display Absorbed Doses? Dosimetry from Single-Activity-Concentration Measurements
Heribert Haenscheid et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
Dosimetry after peptide receptor radionuclide therapy: impact of reduced number of post-treatment studies on absorbed dose calculation and on patient management
Alexandre Chicheportiche et al.
EJNMMI PHYSICS (2020)
Personalized radiation dosimetry for PRRT-how many scans are really required?
Nanette Freedman et al.
EJNMMI PHYSICS (2020)
Kidney dosimetry in 777 patients during 177Lu-DOTATATE therapy: aspects on extrapolations and measurement time points
Mattias Sandstrom et al.
EJNMMI PHYSICS (2020)
Technical Note: Simplified and practical pretherapy tumor dosimetry - A feasibility study for 131I-MIBG therapy of neuroblastoma using 124I-MIBG PET/CT
Youngho Seo et al.
MEDICAL PHYSICS (2019)
Dosimetry of 177Lu-PSMA-617 after Mannitol Infusion and Glutamate Tablet Administration: Preliminary Results of EUDRACT/RSO 2016-002732-32 IRST Protocol
Anna Sarnelli et al.
MOLECULES (2019)
Accuracy of kidney dosimetry performed using simplified time activity curve modelling methods: a 177Lu-DOTATATE patient study
Wei Zhao et al.
PHYSICS IN MEDICINE AND BIOLOGY (2019)
Dosimetry of 177Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer: Correlations Between Pretherapeutic Imaging and Whole-Body Tumor Dosimetry with Treatment Outcomes
John Violet et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Dose Mapping After Endoradiotherapy with Lu-177-DOTATATE/DOTATOC by a Single Measurement After 4 Days
Heribert Haenscheid et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Technical Note: Single time point dose estimate for exponential clearance
Mark T. Madsen et al.
MEDICAL PHYSICS (2018)
EANM practical guidance on uncertainty analysis for molecular radiotherapy absorbed dose calculations
Jonathan I. Gear et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Accuracy and reproducibility of simplified QSPECT dosimetry for personalized 177Lu-octreotate PRRT
Michela Del Prete et al.
EJNMMI PHYSICS (2018)
Feasibility of simplifying renal dosimetry in 177Lu peptide receptor radionuclide therapy
Anna Sundlov et al.
EJNMMI PHYSICS (2018)
Feasibility and accuracy of single time point imaging for renal dosimetry following 177Lu-DOTATATE (Lutate') therapy
Kathy P. Willowson et al.
EJNMMI PHYSICS (2018)
Individualised 177Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry
Anna Sundlov et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
Dosimetry-based treatment planning for molecular radiotherapy: a summary of the 2017 report from the Internal Dosimetry Task Force
Caroline Stokke et al.
EJNMMI PHYSICS (2017)
Effect of calculation method on kidney dosimetry in 177Lu-octreotate treatment
Jorma Heikkonen et al.
ACTA ONCOLOGICA (2016)
Treatment of hyperthyroidism with radioiodine targeted activity: A comparison between two dosimetric methods
Ernesto Amato et al.
PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS (2016)
Uncertainty propagation for SPECT/CT-based renal dosimetry in 177Lu peptide receptor radionuclide therapy
Johan Gustafsson et al.
PHYSICS IN MEDICINE AND BIOLOGY (2015)
Thyroid Cancer: Radiation Safety Precautions in 131I Therapy Based on Actual Biokinetic Measurements
Bin Liu et al.
RADIOLOGY (2014)
Dosimetry prior to I-131-therapy of benign thyroid disease
Heribert Haenscheid et al.
ZEITSCHRIFT FUR MEDIZINISCHE PHYSIK (2011)
Optimized 124I PET dosimetry protocol for radioiodine therapy of differentiated thyroid cancer
Walter Jentzen et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Physical and chemical properties of radionuclide therapy
BW Wessels et al.
SEMINARS IN RADIATION ONCOLOGY (2000)